TARSA-LINK Clinical Study

TARSA-LINK Clinical Study

Life Spine Announces Initiation of TARSA-LINK Stand-Alone Wedge Fixation System Clinical Study

August 02, 2019

HUNTLEY, Ill.–(BUSINESS WIRE)–Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that their foot and ankle division, Centric Medical, has initiated a TARSA-LINK Stand-Alone Wedge Fixation System Clinical Study with Dr. Christopher Nicholas of Norfolk Foot and Ankle in Norfolk, VA.

“Wedge systems have been utilized for many years to correct flat foot deformities, however outcome studies are necessary to evaluate novel systems such as the TARSA-LINK wedge which is the first option on the market with integrated fixation,” said Dr. Nicholas who is the Principal Investigator for the study.

Randy Lewis, General Manager for Life Spine, noted, “Evaluating the safety and efficacy of our products is essential to Life Spine and Centric Medical. We believe we have developed a more streamlined solution in TARSA-LINK and we are excited to study the data.”

The TARSA-LINK Stand-Alone Wedge Fixation System is available in a variety of footprints and is offered in PEEK and Titanium. As opposed to traditional Evans and Cottons Osteotomy procedures, TARSA-LINK is designed to reduce site irritation due to being flush in the osteotomy site, without the need for supplemental fixation.

About Life Spine

Life Spine is dedicated to improving the quality of life for spinal patients by increasing procedural efficiency and efficacy through innovative design, uncompromising quality standards, and the most technologically advanced manufacturing platforms. Life Spine, which is privately held, is based in Huntley, Illinois. For more information, please visit: http://www.lifespine.com.